- Raised $4.8M Series B, Feb 2024
- Raised $2M A Round Extension, Jan 2022
- Raised $17k grant, Nov 2021
About
PLAS-FREE LTD is a clinical stage HealthTech company specializing in the development and commercialization of vital fluid absorbent devices for blood purification. Founded in 2017, the company focuses on innovative solutions to improve health outcomes and reduce healthcare costs. Their product pipeline aims to address unmet medical needs, particularly in the treatment of massive bleeding and hyperammonemia. The company's main product, ClearPlasma, is a single-use device designed to extract plasminogen, a key protein responsible for dissolving blood clots, from plasma units designated for transfusion, enhancing coagulation and promoting hemostasis. This technology has been proven in multiple clinical trials conducted in Israel and Europe. Additionally, Plas-Free is developing the Ammonia Adsorption Column-300 (AAPC-300), designed to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials.
Funding history · 6 rounds · $9.2M total
Headcount over time
Q&A
- What is PLAS-FREE's primary focus?
- PLAS-FREE is a clinical stage HealthTech company that develops and commercializes vital fluid absorbent devices for blood purification, focusing on treatments for massive bleeding and hyperammonemia.
- What is PLAS-FREE's main product?
- PLAS-FREE's main product is ClearPlasma, a single-use device designed to extract plasminogen from plasma units for transfusion, which enhances coagulation and promotes hemostasis. This technology has been proven in multiple clinical trials in Israel and Europe.
- What other product is PLAS-FREE developing?
- PLAS-FREE is developing the Ammonia Adsorption Column-300 (AAPC-300), which is designed to reduce toxic accumulation in patients with liver failure. This technology is currently in pre-clinical trials.
- When was PLAS-FREE founded?
- PLAS-FREE was founded in August 2017.
- How many employees does PLAS-FREE currently have?
- PLAS-FREE has 11-50 employees.
- What was PLAS-FREE's most recent funding round?
- PLAS-FREE completed an A Round in March 2024, raising $4,750,000.
- Which investor participated in PLAS-FREE's initial Seed round?
- NGT3 participated in PLAS-FREE's Seed round in August 2017.
- Has PLAS-FREE received any grants recently?
- PLAS-FREE received a grant in July 2023.
- What is the total amount of funding PLAS-FREE has raised to date?
- PLAS-FREE has raised a total of $10,652,519.
- What is the current stage of PLAS-FREE's product development?
- PLAS-FREE's product is in the clinical trial stage.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | plas-free.com/ |
|---|---|
| linkedin.com/company/27098247 |
Identifiers & details
| Legal name | PLAS-FREE LTD |
|---|---|
| Founded | 2017-8 |
| Employees (exact) | 20 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | plas-free.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515684009 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-07-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ואדי אל-חאג' 13 נצרת |